Relationship between elevated XXXX phosphokinase and the clinical spectrum of @entity5925 .

@entity1 @entity8 @entity167 @entity908 @entity772 @entity177 @entity5925 @entity810 @entity972 @entity460
The incidence, causes and complications of severe @entity5925 ( @entity908 phosphokinase (CK) > or = 5000 U/l) were studied during a 7-year study period in a large university hospital population. This condition was present in 0.074% of all admitted @entity1 . The mortality in the study group (n = 93) was 32% and the incidence of @entity810 ( @entity810 ) 51%. Ischaemia was the most frequent cause, and drugs, @entity167 and/or @entity772 were the second most common cause of severe @entity5925 . @entity1 with @entity5925 due to ischaemia were older, had @entity810 more often, and also had the highest mortality. Hyperkalaemia ( @entity972 > or = 5.5 mmol/l) occurred in 13% of the @entity1 , and all of them had or developed an @entity8 . Hypocalcaemia ( @entity460 < or = 2.00 mmol/l) was found in 41%. The incidence of @entity810 and electrolyte disturbances was higher in @entity1 with CK levels exceeding 15,000 U/l. Mortality was significantly higher in @entity1 with @entity810 . Plasma concentrations of @entity972 and @entity460 correlated better with the severity of @entity177 than with the maximal height of plasma CK.
